$0.75
-0.01 (-0.68%)
Open$0.71
Previous Close$0.75
Day High$0.79
Day Low$0.68
52W High$2.25
52W Low$0.58
Volume—
Avg Volume942.5K
Market Cap39.25M
P/E Ratio—
EPS$-1.07
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+4,271.8% upside
Current
$0.75
$0.75
Target
$32.57
$32.57
$26.16
$32.57 avg
$50.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 10.28M | 9.86M | 9.80M |
| Net Income | -1,154,434 | -865,846 | -1,110,362 |
| Profit Margin | -11.2% | -8.8% | -11.3% |
| EBITDA | -1,433,621 | -1,413,990 | -1,277,421 |
| Free Cash Flow | -904,387 | -870,700 | -861,997 |
| Rev Growth | +11.1% | +6.2% | +2.7% |
| Debt/Equity | 0.32 | 0.28 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |